Core Insights - New Zhi Bio, the first stock in life science instruments listed on the Beijing Stock Exchange, emphasizes the importance of innovation and capital support for small and medium-sized enterprises [2][3] Company Overview - New Zhi Bio is one of the earliest companies in China focused on the research, production, and sales of life science instruments, with over 20 product lines and more than 200 product models [3] - The company has transitioned from a laboratory equipment supplier to a comprehensive service provider covering the entire process from experimentation to mass production [3][4] Product Development - The company continues to innovate in traditional product lines while expanding new product lines, including customized models for various industries, maintaining a stable customized business ratio of over 20% [3][4] - New Zhi Bio has achieved significant technological breakthroughs in ultrasonic processing and freeze-drying, enabling the development of industrial-grade products [3] Strategic Expansion - The company is focusing on integrating capital to accelerate industrial consolidation, exemplified by the acquisition of a 55% stake in Ningbo Afus Constant Temperature Company to enhance its industrial temperature control solutions [4] - New Zhi Bio is shifting its strategic focus towards high-end instruments and global expansion, leveraging the increasing emphasis on independent control of scientific instruments at the national level [5][6] Market Positioning - The company has reached a critical stage in achieving independent control over life science instruments, with some products nearing or surpassing international advanced levels [6] - New Zhi Bio plans to establish a localized service network for its overseas markets, moving from reliance on foreign distributors to a direct service model [6] Capital Market Insights - The Beijing Stock Exchange has played a crucial role in supporting innovative small and medium-sized enterprises, fostering a development pattern that balances quantity and quality [7] - The listing has enhanced the company's brand influence, talent attraction, and shareholder structure, allowing it to compete effectively in the talent market [7] - New Zhi Bio aims to become a "research supermarket" and a provider of comprehensive solutions, leveraging opportunities for collaboration with leading companies in niche markets [7]
新芝生物：攻坚中高端市场 加速全球化布局